Erdafitinib in Metastatic Steroid-cell Ovarian Cancer

NCT06328491 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

1

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer
Steroid Cell Tumor, Malignant

Interventions

DRUG: Erdafitinib

Sponsor

University Health Network, Toronto